Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-09 Sabag Mark EVP, International Markets Option exercise +15,523 74,005
2022-02-09 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −15,523 0
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +16,121 57,532.51
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Sale −6,116 $9.06 $55K 51,416.51
2022-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −16,121 0
2022-02-09 Drape Eric Executive VP Global Operations Option exercise +6,568 39,696
2022-02-09 Drape Eric Executive VP Global Operations Sale −3,583 $9.06 $32K 36,113
2022-02-09 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −6,568 0
2022-02-09 Dethlefs Sven EVP, North America Commercial Option exercise +13,135 91,111
2022-02-09 Dethlefs Sven EVP, North America Commercial Sale −4,138 $9.06 $37K 86,973
2022-02-09 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −13,135 0
2022-02-09 Daniell Richard Exec. VP, European Commercial Option exercise +13,135 33,415
2022-02-09 Daniell Richard Exec. VP, European Commercial Sale −13,135 $9.06 $119K 20,280
2022-02-09 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −13,135 0
2022-02-08 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +37,939 37,939
2022-02-08 Schultz Kare President and CEO Grant or award · Restricted Share Units +162,593 162,593
2022-02-08 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +43,358 43,358
2022-02-08 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +51,488 51,488
2022-02-08 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +32,518 32,518
2022-02-08 Dethlefs Sven EVP, North America Commercial Grant or award · Restricted Share Units +37,939 37,939

Page 42 of 76 · 1,517 trades